Health IT Outcomes: House Set To Tackle Busy HIT Agenda
Dec. 11, 2014
Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) launched the bipartisan 21st Century Cures initiative earlier this year to examine the full arc of the cures process, from discovery, to development, to delivery. Last month, they joined in the 2014 Partnering for Cures event in New York City to promote collaboration and accelerate the pace of cures in America.
Cornell Dean's Blog: Turning Discoveries Into Cures
Nov. 20, 2014
[Dean Laurie H. Glimcher, MD] was joined by Rep. Fred Upton (R-MI), chairman of the House Energy and Commerce Committee, Diana DeGette (D-CO), also a member of the committee, FasterCures Founder Michael Milken, and Anna Barker, co-director of Arizona State University's Complex Adaptive Systems Initiative. Representatives Upton and DeGette spoke about their 21st Century Cures Initiative, a bipartisan effort that aims to speed the approval of drugs and devices by streamlining government processes.
Fox News: 'Partnering for Cures': Medical innovators team up to treat deadly diseases
Nov. 20, 2014
Team work. That was the theme when medical thought leaders converged on New York City recently for the FasterCures Partnering for Cures conference where Fox News’ own Dr. Manny Alvarez was a panel moderator. The event brings together medical experts, policy makers, industry leaders, and philanthropists to share ideas on how they can work together to speed the research and development of cures for the world’s most devastating diseases.
Muscular Dystrophy News: Partnering for Cures Conference to Host CureDuchenne and Prosensa Presentation
Nov. 18, 2014
The national nonprofit organization CureDuchenne and biotechnology company Prosensa Holding, both of which are committed to finding a cure for Duchenne muscular dystrophy in different ways, recently presented a collaborative project at the 6th annual Partnering for Cures event. The conference, which is wrapping up today in New York City, gathered about 1,000 medical research leaders, investors, and decision-makers in order to enhance partnerships to accelerate and improve the outcomes from research on the disease.
CNBC: Advances in Medical Research
Nov. 17, 2014
At the sixth annual Partnering for Cures, FasterCures Founder and Chairman Michael Milken and National Institutes of Health Director Francis Collins sat down with CNBC reporter Meg Tirrell to discuss the importance of supporting medical research and continued innovation in science.
CNBC: Nightly Business Report
Nov. 17, 2014
With government funding for medical research under pressure, the annual Partnering for Cures Conference took place in New York City today on how best to secure industry and philanthropic funding for medical advances. In this interview, Meg Tirrell, Nightly Business Report correspondent, speaks with Michael Milken of the Milken Institute and FasterCures, Francis Collins of the National Institues of Health, and Sonia Vallabh of the Prion Alliance.
Pharmaceutical Law & Industry Report: Backers of 21st Century Cures Bill Look for Enactment by End of 2015
Nov. 17, 2014
Supporters of a bipartisan effort to boost biomedical research toward new treatments and cures are aiming for enactment of a bill before the end of 2015, as the next presidential election year approaches, the chairman of the House Energy and Commerce Committee said Nov. 17. Rep. Fred Upton (R-Mich.), speaking on a panel at a Milken Institute Partnering for Cures conference in New York, laid out a timetable for the 21st Century Cures Initiative that he said would seek to avoid “the funny season” of 2016 presidential election politics.
Huffington Post's Healthy Living: Becoming Your Best Cancer Care Advocate: 5 Steps Could Make All the Difference
Nov. 17, 2014
At an event this week organized by FasterCures, I will have the honor of speaking alongside several inspiring patient advocates, and offer these five steps for coping well. Each step, I believe, can help patients take control of their care and ensure that they get the individualized attention they deserve for the long term.
Upton and DeGette, Morning Joe, and the #Path2Cures
Nov. 17, 2014
Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) this morning joined the Morning Joe team on MSNBC to discuss the bipartisan 21st Century Cures initiative. Their goal from the beginning has been to accelerate the pace of cures in America and bring our laws up to date with the incredible advances we have made in technology, health care, and innovation.
HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery
Nov. 17, 2014
HemoShear and Children's National Health System (CNHS) together will present at the 6th annual Partnering for Cures conference to be held November 16-18, 2014 in New York City. Marshall Summar, MD, Division Chief of Genetics and Metabolism at CNHS, and Brian Wamhoff, PhD, Vice President of R&D and Co-founder of HemoShear, will introduce a new paradigm for enabling discovery of new rare disease treatments in less time and with higher success rates.
Beyond Batten Disease Foundation and the New York Stem Cell Foundation Chosen as a National Innovator by the Milken Institute as They Partner to Find a Cure for Batten
Nov. 17, 2014
Beyond Batten Disease Foundation (BBDF) and the New York Stem Cell Foundation (NYSCF) have been selected as a national innovator by the Milken Institute and will present their breakthrough findings about juvenile Batten disease at the 6th annual Partnering for Cures, November 16-18 in New York City. The presentation will highlight the collaborative efforts of NYSCF, BBDF, and Batten Disease Support and Research Association.
GLG Pharma Attending FasterCures' Partnering for Cures Nov. 16-18 NYC
Nov. 15, 2014
GLG Pharma will be attending FasterCures' Partnering for Cures in New York City on November 16 through 18. The program is a matching of entrepreneurs looking for capital, investors and pharma companies looking for new ideas and technologies. The event is also peppered with researchers and patient advocacy groups as well as not-for-profits funding research organizations across a variety of diseases.
Upton: “21st Century Cures is a top priority at the Energy and Commerce Committee…”
Nov. 14, 2014
Next week, Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) will join patients as well as medical entrepreneurs, researchers, and experts at the 2014 Partnering for Cures event in New York City in an effort to promote collaboration and accelerate the pace of cures in America. As FasterCures states, “this unique meeting connects decision-makers from across diseases that are motivated by the same mission – to reduce the time and cost of getting new medical solutions from discovery to patients.”
Cure Duchenne and Prosensa to Present Collaboration at Partnering for Cures Conference
Nov. 12, 2014
CureDuchenne and Prosensa Holding have been selected to present at the 6thannual Partnering for Cures, November 16-18 in New York City. Convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, the conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D. CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, and Prosensa, the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, will present “Accelerating Access to Treatments of Duchenne Muscular Dystrophy” on November 17.
Catalent Applied Drug Delivery Institute Executives Invited to Speak at Partnering For Cures Conference
Nov. 12, 2014
The Catalent Applied Drug Delivery Institute has been selected to present at the 6th annual Partnering for Cures conference, November 16-18 in New York City. Convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, the conference will bring together nearly 1,000 medical research leaders, investors, and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D.
OvaScience to Participate in Partnering for Cures Conference
Nov. 11, 2014
OvaScience, a global life sciences company focused on the discovery, development, and commercialization of new fertility treatments, announced today that Company management will participate in the Partnering for Cures meeting, an event convened by the Milken Institute’s FasterCures. OvaScience will be part of a panel titled, “Collaborative Capital,” on November 18, 2014 at 11:00 a.m. ET at the Grand Hyatt New York. Partnering for Cures brings together decision-makers from across diseases and all sectors of medical research to foster collaborations needed to speed up and improve outcomes-driven research and development.
Top research collaborations explain how they are speeding the path to cures
Oct. 7, 2014
Thirty of the most creative, cross-sector collaborations in medical research will present their models to potential partners and funders at FasterCures’ sixth annual Partnering for Cures meeting, November 16-18 in New York City. Selected through a competitive proposal process, these partnerships are aimed at reducing the time and cost of getting new medical solutions from discovery to patients.
“The quality of our over 120 applicants – more than twice the submissions of previous years – was terrific and made for a particularly difficult decision-making process,” said FasterCures’ Executive Director Margaret Anderson. “These collaborations address some of the thorniest issues in medical research using models that can be scaled and translated across diseases and sectors.”
From re-imagining clinical trial infrastructure to improving and expanding data sharing to creating the tools and resources needed to translate basic science into cures, these innovators are accelerating the path from lab to market for novel – and needed – therapies.
For example, 2014 presenters include:
- The first-ever public-private partnership focused on advancing the regulatory science of medical devices
- An effort that harnesses the power of high-performance computing to “hack” brain disease
- One of the first clinical trials to address coverage with evidence development
- A collaboration that blazes a trail for successful reimbursement of disruptive technologies
- An outcome assessments consortium that identified and validated a new measure of disability for use as a primary endpoint in multiple sclerosis trials
- And many more . . .
With nearly one-third of the 120 applicants indicating that their collaborations were either established or enhanced as the result of participating in past Partnering for Cures, the meeting remains a key venue for innovators across the ecosystem to unite and share ideas.
We invite you to attend these presentations and glimpse the future of medical R&D. By engaging patients as trusted partners in the drug development process and by working together – across labs, companies, borders and sectors – these partnerships provide a shining example of transformation in action.
For questions, please contact: